Skip to main content
Tech.euFundingExplorerBeta

ReViral

Exited

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

Stevenage, UKFounded 2011www.reviral.co.uk ↗
Healthtech
← All companies
Total raised
€37M
€37,227,300
Funding rounds
1
Investors
1
distinct backers
Active since
2020-08
latest 2020-08

Funding by year

EUR raised per year

Funding rounds

1 rounds
DateStageAmountInvestors
2020-08-27Series C€37MCR-CP Life Science FundView deal →

Exit

Type
acquisition
Date
Apr 2022
Value
€483M
Acquiror
Pfizer (United States of America)

Investors

1
CR-CP Life Science Fund

Related news

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €5.0B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B